Sanofi

CAC 40Health careSANFR0000120578

A. is a French multinational pharmaceutical and healthcare company headquartered in Paris.

Filings

431 filings

All Inside information267 Share buyback113 Voting rights and capital36 Earnings release9 Half-year financial report2 Universal registration document2 Threshold crossing1 Annual financial report1

22/09/2025
Communiqué de presse : Mise à jour sur l’examen réglementaire américain du tolébrutinib dans le traitement de la sclérose en plaques secondairement progressive non récurrente
Inside informationFrench
22/09/2025
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Inside informationFR
17/09/2025
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Inside informationFR
15/09/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
12/09/2025
Sanofi: Information concerning the total number of voting rights and shares - August 2025
Voting rights and capitalFR
11/09/2025
Communiqué de presse : Le SAR402663 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de la dégénérescence maculaire liée à l’âge néovasculaire
Inside informationFrench
10/09/2025
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
Inside informationFR
08/09/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
04/09/2025
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis
Inside informationFR
02/09/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
29/08/2025
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Inside informationFR
25/08/2025
Sanofi: Disclosure of trading in own shares
Share buyback
18/08/2025
Sanofi: Information concerning the total number of voting rights and shares - July 2025
Voting rights and capitalFR
18/08/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
14/08/2025
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Inside informationFR
11/08/2025
Sanofi: Disclosure of trading in own shares
Share buyback
06/08/2025
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
Inside informationFR
04/08/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
31/07/2025
Press release: Online availability of Sanofi’s half-year financial report for 2025
Inside informationFR
31/07/2025
Sanofi - Rapport semestriel 2025
Half-year financial reportFrench
31/07/2025
Communiqué de presse : T2 : croissance à deux chiffres desventes, nette progression du BNPA des activités ; perspectives de ventes 2025 revues à la hausse avec une croissance désormais attendue dans le haut de la fourchette à un chiffre
Inside informationFrench
31/07/2025
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
Earnings release
30/07/2025
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
Inside informationFR
25/07/2025
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
Inside informationFR
22/07/2025
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Inside informationFR
21/07/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
18/07/2025
Press Release: Sanofi completes acquisition of Blueprint Medicines
Inside informationFR
17/07/2025
Communiqué de presse : Sanofi annonce la prolongation de l’offre publique d’achat sur Blueprint
Inside informationFrench
16/07/2025
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Inside informationFR
15/07/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
09/07/2025
Sanofi: Information concerning the total number of voting rights and shares - June 2025
Voting rights and capitalFR
07/07/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
30/06/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
30/06/2025
Press release: Availability of the Q2 2025 Aide mémoire
Inside informationFR
30/06/2025
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
Inside informationFR
25/06/2025
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Inside informationFR
24/06/2025
Sanofi : Déclaration des transactions sur actions propres
Share buybackFrench
23/06/2025
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
Inside informationFR
20/06/2025
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Inside informationFR
17/06/2025
Press release: Sanofi successfully prices €1.5 billion bond issue
Inside informationFR
16/06/2025
Sanofi: Disclosure of trading in own shares
Share buybackFR
15/06/2025
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Inside informationFR
09/06/2025
Sanofi: Information concerning the total number of voting rights and shares - May 2025
Voting rights and capitalFR
09/06/2025
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Inside informationFR
06/06/2025
Sanofi: Disclosure of trading in own shares
Share buyback

About

ISIN: FR0000120578
Ticker: SAN
LEI: 549300E9PC51EN656011
Sector: Health care
Founded: 2004
Employees: 106,566
Country of registration: FR
Last filing: 04/08/2026, 07:00

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive